Nuclear Receptors and Gene Regulation

Nuclear Receptors - Cellular Gatekeepers

• Definition: Ligand-activated transcription factors that bind DNA, regulating gene expression.
• General Structure:
  • N-terminal Domain (NTD/AF-1): Transcriptional activation (AF-1).
  • DNA-Binding Domain (DBD): Conserved; two zinc fingers for DNA binding.
  • Hinge Region: Flexible linker; nuclear localization.
  • Ligand-Binding Domain (LBD/AF-2): Binds ligands; dimerization, cofactor interaction (AF-2).
• Location: Cytoplasm (e.g., steroid receptors) or nucleus (e.g., TR, RAR).

⭐ The DNA binding domain (DBD) of NRs contains two zinc fingers, crucial for binding specific DNA sequences (Hormone Response Elements).

Receptor Roundup - Meet the Family

Nuclear Receptors (NRs): Key transcription factors, classified as:

• Orphan Receptors: NRs with unknown or uncharacterized endogenous ligands.

⭐ Type II nuclear receptors typically heterodimerize with Retinoid X Receptor (RXR).

Action Stations! - Receptor Mechanics

• Ligand Binding (LBD): Initiates conformational change in the receptor.
• Type I Receptors (e.g., Steroids - Glucocorticoids, Estrogen):
  • Primarily cytosolic/nuclear.
  • Ligand binding → Heat Shock Protein (HSP) dissociation → Dimerization → Nuclear translocation.
• Type II Receptors (e.g., Thyroid hormone, Vitamin D, Retinoids):
  • Predominantly nuclear, often bound to DNA with co-repressors.
  • Ligand binding → Co-repressor dissociation & Co-activator recruitment.
• DNA Interaction: Activated receptor-ligand complex binds to specific DNA sequences called Hormone Response Elements (HREs) via its DNA Binding Domain (DBD).
• Gene Regulation:
  • Co-activators (e.g., HATs like CBP/p300) recruited → Histone acetylation → Chromatin decondensation → ↑Gene transcription.
  • Co-repressors (e.g., HDACs like NCoR, SMRT) recruited → Histone deacetylation → Chromatin condensation → ↓Gene transcription.

⭐ Co-activators like HATs (Histone Acetyltransferases) acetylate histones, leading to chromatin decondensation and facilitating gene activation. Co-repressors often involve HDACs (Histone Deacetylases) causing gene repression.

Gene Bosses - Transcriptional Control

• Activation: Nuclear Receptors (NRs) + co-activators (e.g., HATs, SWI/SNF) remodel chromatin, recruit General Transcription Factors (GTFs) & RNA Pol II → gene expression ↑.
• Repression: NRs + co-repressors (e.g., HDACs) condense chromatin, compete for DNA binding sites, or directly inhibit transcription machinery → gene expression ↓.
• Example: Glucocorticoid Receptor (GR) activates PEPCK gene.

⭐ Tamoxifen, a Selective Estrogen Receptor Modulator (SERM), acts as an antagonist in breast tissue (inhibiting estrogen-dependent cancer growth) but an agonist in bone (preventing osteoporosis) and uterus (risk of endometrial hyperplasia).

Clinical Cameos - Receptors in Disease

• Pathologies (Receptor Gene Mutations):
  • Androgen Insensitivity Syndrome (AIS): AR.

    ⭐ Mutations in the Androgen Receptor (AR) gene cause Androgen Insensitivity Syndrome, resulting in a female phenotype in XY individuals.

  • Vitamin D-Resistant Rickets (Type II): VDR.
  • Breast Cancer: Estrogen Receptor (ER) positive.
• Therapeutic Targeting (Examples):
  • Glucocorticoids: Anti-inflammatory.
  • Tamoxifen: ER modulator (breast cancer).
  • Raloxifene: SERM (osteoporosis).
  • Fibrates: PPARα agonists (hyperlipidemia).
  • Thiazolidinediones: PPARγ agonists (type 2 diabetes).

High‑Yield Points - ⚡ Biggest Takeaways

• Nuclear receptors are ligand-activated transcription factors that directly regulate gene expression.
• They bind DNA at specific sequences: Hormone Response Elements (HREs).
• Type I receptors (e.g., steroid) are often cytoplasmic, homodimerize, then translocate to bind HREs.
• Type II receptors (e.g., thyroid, Vit D) are nuclear, heterodimerize with RXR, and can bind DNA without ligand.
• Their DNA-binding domain (DBD) typically contains zinc finger motifs.
• Transcriptional output is fine-tuned by co-activators and co-repressors.